Mangat, Pam K.

Palbociclib in Patients With Pancreatic and Biliary Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study

Al Baghdadi, T., Halabi, S., Garrett-Mayer, E., Mangat, P. K., Ahn, E. R., Sahai, V., Alvarez, R. H., Kim, E. S., Yost, K. J., Rygiel, A. L., et al. (2019) · JCO Precision Oncology

Pancreatic and Hepatic Oncology ResearchAdvanced Breast Cancer Therapies

Cited by 94

Pertuzumab plus trastuzumab (P+T) in patients (Pts) with colorectal cancer (CRC) with ERBB2 amplification or overexpression: Results from the TAPUR Study.

Gupta, R., Garrett-Mayer, E., Halabi, S., Mangat, P. K., D'Andre, S. D., Meiri, E., Shrestha, S., Warren, S. L., Ranasinghe, S., & Schilsky, R. L. (2020) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research

Cited by 41